首页 | 本学科首页   官方微博 | 高级检索  
     

徐长卿提取物对损伤内皮细胞中乳酸脱氢酶、肿瘤坏死因子及白细胞介素-8活性的影响
引用本文:李阳,孙世光,谢予朋,孙晓迪,闫荟,石亚飞. 徐长卿提取物对损伤内皮细胞中乳酸脱氢酶、肿瘤坏死因子及白细胞介素-8活性的影响[J]. 中国医药导报, 2013, 10(28): 10-12
作者姓名:李阳  孙世光  谢予朋  孙晓迪  闫荟  石亚飞
作者单位:1. 北京军区总医院药剂科,北京 100700;河北北方学院研究生部,河北张家口 075000
2. 北京军区总医院药剂科,北京,100700
3. 河北北方学院研究生部,河北张家口,075000
基金项目:国家自然科学基金资助项目
摘    要:目的 研究徐长卿提取物对损伤内皮细胞中炎症介质乳酸脱氢酶(LDH)、肿瘤坏死因子(TNF-α)及白细胞介素-8(IL-8)活性的调节作用,探究徐长卿治疗动脉粥样硬化的作用机制.方法 应用补体蛋白纯品于体外在人脐静脉内皮细胞表面组装亚溶破剂量的C5b-9,建立内皮损伤模型,分别建立提取物高、中、低剂量组及空白、模型及标准品对照组,分别用不同浓度的徐长卿提取物及丹皮酚标准品处理细胞,应用紫外分光光度法及ELISA试剂盒测定细胞培养上清液中LDH、TNF-α及IL-8浓度.结果 提取物高剂量组LDH[(119.85±4.12)U/L]及IL-8[(33.65±2.48)ng/L]与模型对照组[(200.49±3.31) U/L,(40.98±0.60)ng/L]比较,差异有高度统计学意义(P<0.01);高剂量[(94.75±3.19)ng/L]及中剂量组[(92.81±1.78)ng/L]与模型对照组[(108.00±2.30)ng/L]比较,均可降低TNF-α水平(P< 0.01).结论 徐长卿可能通过降低炎症介质LDH、TNF-α及IL-8活性,从而修复内皮细胞损伤来达到治疗动脉粥样硬化的目的.

关 键 词:徐长卿提取物  乳酸脱氢酶  肿瘤坏死因子  白细胞介素-8  攻膜复合物C5b-9

The infuence of Cynanchum Extract on lactate dehydrogenase, tumor necrosis factor and interleukin-8 activity in endothelial injury cells
LI Yang , SUN Shiguang , XIE Yupeng , SUN Xiaodi , YAN Hui , SHI Yafei. The infuence of Cynanchum Extract on lactate dehydrogenase, tumor necrosis factor and interleukin-8 activity in endothelial injury cells[J]. China Medical Herald, 2013, 10(28): 10-12
Authors:LI Yang    SUN Shiguang    XIE Yupeng    SUN Xiaodi    YAN Hui    SHI Yafei
Affiliation:LI Yang(Department of Pharmacy, Beijing Military General Hospital of PLA, Beijing 100700, China;Department of Graduate,Hebei North University, Hebei Province, Zhangjiakou 075000, China) SUN Shiguang(Department of Pharmacy, Beijing Military General Hospital of PLA, Beijing 100700, China) XIE Yupeng(Department of Pharmacy, Beijing Military General Hospital of PLA, Beijing 100700, China) SUN Xiaodi(Department of Pharmacy, Beijing Military General Hospital of PLA, Beijing 100700, China) YAN Hui(Department of Pharmacy, Beijing Military General Hospital of PLA, Beijing 100700, China) SHI Yafei(Department of Graduate,Hebei North University, Hebei Province, Zhangjiakou 075000, China)
Abstract:Objective To research the regulation of Cynanchum Extract for inflammatory mediators LDH,TNF-α and IL-8 in endothelial cells,and explore the mechanism of Cynanchum treatment of atherosclerosis.Methods The sublysis dose of C5b-9 was assembled on human umbilical vein endothelial cell surface in vitro by pure complement proteins,and endothelial injury model was established.Extract of high,middle and low doses,model and standard groups were built; cells were cultured in different concentration drugs.Then the concentration of LDH,TNF-α and IL-8 in cell culture supernatant was measured by UV and ELISA kits.Results LDH and IL-8 activity reduced in extract high-dose group [(119.85±4.12) U/L] and IL-8 [(33.65±2.48) ng/L] significantly,compared with model control group [(200.49±3.31) U/L,(40.98±0.60) ng/L] had statistically significant difference (P < 0.01).TNF-α level reduced in high-dose [(94.75±3.19) ng/L] and medium-dose groups [(92.81± 1.78) ng/L],compared with model control group [(108.00±2.30) ng/L] had statistically significant difference (P < 0.01).Conclusion Cynanchum may repair endothelial injury cells for therapy atherosclerosis by reducing the activity of inflammatory mediators LDH,TNF-α and IL-8.
Keywords:Cynanchum Extract  Lactate dehydrogenase  Tumor necrosis factor  ,Interleukin-8  Complement membrane attack complex C5b-9
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号